While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially ...

In a new study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25), South Korean researchers report that for patients at high risk for bleeding following stent ...

The new study sought to determine whether some higher-risk patients might benefit from continuing to take clopidogrel, a more potent antiplatelet medication, instead of aspirin following DAPT.

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

However, Kim said, the findings on optimal DAPT duration could potentially be applied regardless of the drug type. After the presentation, Anna E. Bortnick, MD, PhD, MSc, FACC, associate director ...

For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with ...

While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially ...